MediVet, an animal healthcare company and OEM partner, has developed patented stem cell regenerative medicine for the animal healthcare sector.
MLA will become the sole distributor for MediVet’s products in England, Wales, Scotland and Ireland.
The company is marketing the MediVet stem cell process to veterinary clinics and equine centres across the UK.
MLA CEO Mark Donnison said given MLA is MediVet’s OEM partner, they are placed to control the entire supply chain for these new markets, from manufacturing through to sales and distribution.
"The new organic growth development is another avenue to fast track revenue growth from FY2012 onwards whilst at the same time delivering acceptable margins," Donnison said.
MLA products include intravenous (IV) medication delivery systems, surgical irrigation, suction and oxygen therapy, safety sharps collection and reuse prevention and specialised diagnostic and laboratory equipment.
